5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
12.25%
Positive revenue growth while VALMT.HE is negative. John Neff might see a notable competitive edge here.
44.98%
Positive gross profit growth while VALMT.HE is negative. John Neff would see a clear operational edge over the competitor.
21.04%
Positive EBIT growth while VALMT.HE is negative. John Neff might see a substantial edge in operational management.
21.04%
Positive operating income growth while VALMT.HE is negative. John Neff might view this as a competitive edge in operations.
60.67%
Positive net income growth while VALMT.HE is negative. John Neff might see a big relative performance advantage.
63.16%
Positive EPS growth while VALMT.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
63.16%
Positive diluted EPS growth while VALMT.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
-1.53%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-22.70%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-40.00%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-8.68%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 52.58%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
25.96%
5Y revenue/share CAGR at 50-75% of VALMT.HE's 43.48%. Martin Whitman would worry about a lagging mid-term growth trajectory.
17.83%
3Y revenue/share CAGR under 50% of VALMT.HE's 40.06%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
182.79%
10Y OCF/share CAGR under 50% of VALMT.HE's 481.09%. Michael Burry would worry about a persistent underperformance in cash creation.
247.97%
Positive OCF/share growth while VALMT.HE is negative. John Neff might see a comparative advantage in operational cash viability.
150.87%
Positive 3Y OCF/share CAGR while VALMT.HE is negative. John Neff might see a big short-term edge in operational efficiency.
731.07%
Net income/share CAGR above 1.5x VALMT.HE's 276.08% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
211.38%
5Y net income/share CAGR 1.25-1.5x VALMT.HE's 150.72%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
83.17%
3Y net income/share CAGR above 1.5x VALMT.HE's 45.28%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
99.05%
10Y equity/share CAGR above 1.5x VALMT.HE's 42.27%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
57.70%
5Y equity/share CAGR 1.25-1.5x VALMT.HE's 48.88%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
31.43%
3Y equity/share CAGR at 50-75% of VALMT.HE's 43.29%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.89%
AR growth well above VALMT.HE's 10.80%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.56%
Inventory growth well above VALMT.HE's 14.05%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.44%
Positive asset growth while VALMT.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.10%
Positive BV/share change while VALMT.HE is negative. John Neff sees a clear edge over a competitor losing equity.
4.68%
We have some new debt while VALMT.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-3.65%
We cut SG&A while VALMT.HE invests at 102.50%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.